Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other
companies in this sector in the United States:
sales of $22.09 billion
of which 100%
Teva Pharmaceutical Industries Limited
of which 49%
was North America), and
Eli Lilly and Company
of which 48%
was Human pharmaceutical products - Endocrin).
During the year ended December of 2018, sales at
Bristol-Myers Squibb Company were $22.56 billion.
increase of 8.6%
versus 2017, when the company's sales were $20.78 billion.
This was the fourth straight year of sales growth at Bristol-Myers Squibb Company.